IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 1 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,661,000 | -84.3% | 2,047,180 | -55.6% | 0.01% | -81.2% |
Q4 2020 | $16,914,000 | +71.5% | 4,608,786 | 0.0% | 0.06% | +64.1% |
Q3 2020 | $9,863,000 | +19.6% | 4,608,786 | 0.0% | 0.04% | +8.3% |
Q2 2020 | $8,250,000 | +35.6% | 4,608,786 | 0.0% | 0.04% | -2.7% |
Q1 2020 | $6,084,000 | -27.5% | 4,608,786 | 0.0% | 0.04% | -17.8% |
Q4 2019 | $8,388,000 | -37.0% | 4,608,786 | 0.0% | 0.04% | -50.5% |
Q3 2019 | $13,319,000 | +8.3% | 4,608,786 | +0.1% | 0.09% | +8.3% |
Q2 2019 | $12,298,000 | -0.4% | 4,605,822 | -4.8% | 0.08% | +6.3% |
Q1 2019 | $12,342,000 | -7.9% | 4,839,895 | +0.1% | 0.08% | -28.2% |
Q4 2018 | $13,396,000 | -68.9% | 4,836,237 | +0.0% | 0.11% | -61.3% |
Q3 2018 | $43,070,000 | -15.6% | 4,833,897 | -87.5% | 0.28% | -25.8% |
Q2 2018 | $51,024,000 | – | 38,654,811 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 56,250 | $68,000 | 0.23% |
Virtu Financial LLC | 325,330 | $390,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 141,000 | $169,000 | 0.02% |
Clear Creek Financial Management, LLC | 49,696 | $60,000 | 0.01% |
Palo Alto Investors LP | 77,044 | $92,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 738,620 | $886,000 | 0.00% |
MARSHALL WACE, LLP | 477,449 | $573,000 | 0.00% |
WADE G W & INC | 35,000 | $42,000 | 0.00% |
TWO SIGMA ADVISERS, LP | 599,471 | $719,000 | 0.00% |
BRYN MAWR TRUST Co | 33,892 | $41,000 | 0.00% |